Essa Pharma (EPIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 06-2025 | 03-2025 | 12-2024 | 09-2024 | 06-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,910 | -14,907 | -8,532 | -28,543 | -22,188 |
| Depreciation Amortization | 64 | 48 | 23 | 91 | 68 |
| Accounts receivable | -113 | -1 | 9 | -28 | -49 |
| Other Working Capital | -1,489 | -1,891 | -399 | -419 | -709 |
| Other Operating Activity | 2,929 | 3,433 | 2,429 | 6,183 | 3,527 |
| Operating Cash Flow | $-17,519 | $-13,319 | $-6,470 | $-22,716 | $-19,350 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -238 | -4,083 | -3,929 | 91,789 | 70,765 |
| Investing Cash Flow | $-238 | $-4,083 | $-3,929 | $91,789 | $70,765 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | 880 | 820 |
| Common Stock Repurchased | N/A | N/A | N/A | 46 | 46 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $926 | $866 |
| Exchange Rate Effect | N/A | N/A | N/A | 9 | 3 |
| Beginning Cash Position | 103,710 | 103,710 | 103,710 | 33,702 | 33,702 |
| End Cash Position | 85,953 | 86,308 | 93,311 | 103,710 | 85,985 |
| Net Cash Flow | $-17,757 | $-17,401 | $-10,399 | $70,008 | $52,283 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,519 | -13,319 | -6,470 | -22,716 | -19,350 |
| Free Cash Flow | -17,519 | -13,319 | -6,470 | -22,716 | -19,350 |